Suntrust Banks’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-77,080
| Closed | -$1.5M | – | 1393 |
|
|
2018
Q1 | $1.5M | Buy |
77,080
+5,728
| +8% | +$112K | 0.01% | 613 |
|
|
2017
Q4 | $1.19M | Buy |
71,352
+61,352
| +614% | +$1.12M | 0.01% | 657 |
|
|
2017
Q3 | $203K | Buy |
+10,000
| New | +$191K | ﹤0.01% | 1203 |
|
|
2016
Q4 | – | Sell |
-20,883
| Closed | -$494K | – | 1660 |
|
|
2016
Q3 | $494K | Sell |
20,883
-520
| -2% | -$14K | ﹤0.01% | 961 |
|
|
2016
Q2 | $616K | Buy |
21,403
+610
| +3% | +$19.9K | ﹤0.01% | 871 |
|
|
2016
Q1 | $665K | Hold |
20,793
| – | – | ﹤0.01% | 826 |
|
|
2015
Q4 | $889K | Buy |
20,793
+10,793
| +108% | +$431K | 0.01% | 737 |
|
|
2015
Q3 | $352K | Hold |
10,000
| – | – | ﹤0.01% | 961 |
|
|
2015
Q2 | $459K | Hold |
10,000
| – | – | ﹤0.01% | 880 |
|
|
2015
Q1 | $468K | Hold |
10,000
| – | – | ﹤0.01% | 849 |
|
|
2014
Q4 | $316K | Sell |
10,000
-3,169
| -24% | -$92.7K | ﹤0.01% | 959 |
|
|
2014
Q3 | $312K | Sell |
13,169
-233
| -2% | -$5.97K | ﹤0.01% | 1149 |
|
|
2014
Q2 | $401K | Sell |
13,402
-5,806
| -30% | -$157K | ﹤0.01% | 1096 |
|
|
2014
Q1 | $506K | Sell |
19,208
-53,320
| -74% | -$1.33M | ﹤0.01% | 1323 |
|
|
2013
Q4 | $1.82M | Sell |
72,528
-678
| -0.9% | -$15.1K | 0.01% | 699 |
|
|
2013
Q3 | $1.5M | Sell |
73,206
-1,346
| -2% | -$27.8K | 0.01% | 739 |
|
|
2013
Q2 | $1.49M | Buy |
+74,552
| New | +$1.32M | 0.01% | 702 |
|
Suntrust Banks's IPXL Position: Q2 2018 in Review
Suntrust Banks sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 77,080 shares — an estimated $1.5M sold.
Suntrust Banks first reported a position in IPXL in Q2 2013 and held it in 17 quarters. The position peaked at $1.82M in Q4 2013. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Suntrust Banks reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Suntrust Banks sold 77,080 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1.5M.
- Suntrust Banks first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 17 quarters.
- Suntrust Banks's Impax Laboratories, Inc. position peaked at $1.82M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Suntrust Banks's 13F filing for Q2 2018, filed 14 Aug 2018.